To address the effects of DIRAS3 and p53 in HNSCC, CAL-27 and SCC-25 cells were treated with Ad-GFP, Ad-DIRAS3, or rAd-p53 alone or with a combination of Ad-DIRAS3 and rAd-p53. This evidence concerns the gene DIRAS3 and head and neck squamous cell carcinoma.